<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11864864</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.573</article-id><article-id pub-id-type="other">EPP0422</article-id><article-id pub-id-type="pii">S092493382400573X</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Multivariate associations between psychiatric drug intake and grey matter volume changes in individuals at early stages of psychosis and depression</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Weyer</surname><given-names>C.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1308" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cor0434" ref-type="corresp">
<sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Popovic</surname><given-names>D.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1309" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff1310" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ruef</surname><given-names>A.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hahn</surname><given-names>L.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sari&#x0015f;ik</surname><given-names>E.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1309" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff1310" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Fanning</surname><given-names>J.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1310" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kambeitz</surname><given-names>J.</given-names></name><xref rid="aff1311" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Salokangas</surname><given-names>R. K.</given-names></name><xref rid="aff1312" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Hietala</surname><given-names>J.</given-names></name><xref rid="aff1312" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bertolino</surname><given-names>A.</given-names></name><xref rid="aff1313" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Borgwardt</surname><given-names>S.</given-names></name><xref rid="aff1314" ref-type="aff">
<sup>8</sup>
</xref><xref rid="aff1315" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Brambilla</surname><given-names>P.</given-names></name><xref rid="aff1316" ref-type="aff">
<sup>10</sup>
</xref><xref rid="aff1317" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Upthegrove</surname><given-names>R.</given-names></name><xref rid="aff1318" ref-type="aff">
<sup>12</sup>
</xref><xref rid="aff1319" ref-type="aff">
<sup>13</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wood</surname><given-names>S. J.</given-names></name><xref rid="aff1320" ref-type="aff">
<sup>14</sup>
</xref><xref rid="aff1321" ref-type="aff">
<sup>15</sup>
</xref><xref rid="aff1322" ref-type="aff">
<sup>16</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lencer</surname><given-names>R.</given-names></name><xref rid="aff1314" ref-type="aff">
<sup>8</sup>
</xref><xref rid="aff1323" ref-type="aff">
<sup>17</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Meisenzahl</surname><given-names>E.</given-names></name><xref rid="aff1324" ref-type="aff">
<sup>18</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Falkai</surname><given-names>P.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1309" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Koutsouleris</surname><given-names>N.</given-names></name><xref rid="aff1307" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff1309" ref-type="aff">
<sup>3</sup>
</xref><xref rid="aff1325" ref-type="aff">
<sup>19</sup>
</xref></contrib></contrib-group><aff id="aff1307">
<sup>1</sup>Department of Psychiatry and Psychotherapy, <institution>LMU University Hospital</institution>, LMU Munich, <city>Munich</city>
</aff><aff id="aff1308">
<sup>2</sup><institution>Graduate School of Systemic Neurosciences, LMU Munich</institution>, <city>Planegg-Martinsried
</city>
</aff><aff id="aff1309">
<sup>3</sup><institution>Max-Planck Institute of Psychiatry</institution>
</aff><aff id="aff1310">
<sup>4</sup><institution>International Max Planck Research School for Translational Psychiatry (IMPRS-TP)</institution>, <city>Munich</city>
</aff><aff id="aff1311">
<sup>5</sup>Department of Psychiatry and Psychotherapy, <institution>University of Cologne</institution>, <city>Cologne</city>, <country>Germany</country>
</aff><aff id="aff1312">
<sup>6</sup>Department of Psychiatry, <institution>University of Turku</institution>, <city>Turku</city>, <country>Finland</country>
</aff><aff id="aff1313">
<sup>7</sup>Department of Basic Medical Science, Neuroscience and Sense Organs, <institution>University of Bari Aldo Moro</institution>, <city>Bari</city>, <country>Italy</country>
</aff><aff id="aff1314">
<sup>8</sup>Department of Psychiatry and Psychotherapy, <institution>University of L&#x000fc;beck</institution>, <city>L&#x000fc;beck</city>, <country>Germany</country>
</aff><aff id="aff1315">
<sup>9</sup><institution>University of Basel</institution>, Department of Psychiatry (Psychiatric University Hospital, UPK), <city>Basel</city>, <country>Switzerland</country>
</aff><aff id="aff1316">
<sup>10</sup>Department of Neurosciences and Mental Health, <institution>Fondazione IRCCS Ca&#x02019; Granda Ospedale Maggiore Policlinico</institution>
</aff><aff id="aff1317">
<sup>11</sup>Department of Pathophysiology and Transplantation, <institution>University of Milan</institution>, <city>Milan</city>, <country>Italy</country>
</aff><aff id="aff1318">
<sup>12</sup>Institute of Mental Health, <institution>University of Birmingham</institution>
</aff><aff id="aff1319">
<sup>13</sup><institution>Early Intervention Service, Birmingham Women&#x02019;s and Children&#x02019;s NHS Foundation Trust</institution>
</aff><aff id="aff1320">
<sup>14</sup>School of Psychology, <institution>University of Birmingham</institution>, <city>Birmingham</city>, <country>United Kingdom</country>
</aff><aff id="aff1321">
<sup>15</sup>Centre for Youth Mental Health, <institution>University of Melbourne</institution>
</aff><aff id="aff1322">
<sup>16</sup><institution>Orygen</institution>, <city>Melbourne</city>, <country>
Australia</country>
</aff><aff id="aff1323">
<sup>17</sup><institution>Institute for Translational Psychiatry, University M&#x000fc;nster</institution>, <city>M&#x000fc;nster</city>
</aff><aff id="aff1324">
<sup>18</sup>Department of Psychiatry and Psychotherapy, Medical Faculty, <institution>Heinrich Heine University</institution>, <city>D&#x000fc;sseldorf</city>, <country>Germany</country>
</aff><aff id="aff1325">
<sup>19</sup>Institute of Psychiatry, Psychology And Neurosciences, <institution>King&#x02019;s College London</institution>, <city>
London</city>, <country>United Kingdom</country>
</aff><author-notes><corresp id="cor0434">
<label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="548">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S272</fpage><lpage>S273</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S092493382400573Xa.pdf"/><abstract><sec id="sec2605"><title>Introduction</title><p>Psychiatric drugs, including antipsychotics and antidepressants, are widely prescribed, even in young and adolescent populations at early or subthreshold disease stages. However, their impact on brain structure remains elusive. Elucidating the relationship between psychotropic medication and structural brain changes could enhance the understanding of the potential benefits and risks associated with such treatment.</p></sec><sec id="sec2606"><title>Objectives</title><p>
Investigation of the associations between psychiatric drug intake and longitudinal grey matter volume (GMV) changes in a transdiagnostic sample of young individuals at early stages of psychosis or depression using an unbiased data-driven approach.</p></sec><sec id="sec2607"><title>Methods</title><p>
The study sample comprised 247 participants (mean [SD] age = 25.06 [6.13] years, 50.61% male), consisting of young, minimally medicated individuals at clinical high-risk states for psychosis, individuals with recent-onset depression or psychosis, and healthy control individuals. Structural magnetic resonance imaging was used to obtain whole-brain voxel-wise GMV for all participants at two timepoints (mean [SD] time between scans = 11.15 [4.93] months). The multivariate sparse partial least squares (SPLS) algorithm (Monteiro <italic toggle="yes">et al</italic>. JNMEDT 2016; 271:182-194) was embedded in a nested cross-validation framework to identify parsimonious associations between the cumulative intake of psychiatric drugs, including commonly prescribed antipsychotics and antidepressants, and change in GMV between both timepoints, while additionally factoring in age, sex, and diagnosis. Furthermore, we correlated the retrieved SPLS results to personality domains (NEO-FFI) and childhood trauma (CTQ).</p></sec><sec id="sec2608"><title>Results</title><p>SPLS analysis revealed significant associations between the antipsychotic classes of benzamides, butyrophenones and thioxanthenes and longitudinal GMV decreases in cortical regions including the insula, posterior superior temporal sulcus as well as cingulate, postcentral, precentral, orbital and frontal gyri (Figure 1A-C). These brain regions corresponded most closely to the dorsal and ventral attention, somatomotor, salience and default network (Figure 1D). Furthermore, the medication signature was negatively associated with the personality domains extraversion, agreeableness and conscientiousness and positively associated with the CTQ domains&#x000a0;emotional and physical neglect.</p><p>
<bold>Image:</bold></p><p>
<fig position="float" id="fig0063"><graphic xlink:href="S092493382400573X-FIG0063" position="anchor"/></fig>
</p></sec><sec id="sec2609"><title>Conclusions</title><p>Psychiatric drug intake over a period of one year was linked to distinct GMV reductions in key cortical hubs. These patterns were already visible in young individuals at early or subthreshold stages of mental illness and were further linked to childhood neglect and personality traits. Hence, a better and more in-depth understanding of the structural brain implications of medicating young and adolescent individuals might lead to more cautious, sustainable and targeted treatment strategies.</p></sec><sec id="sec2610"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>